Cargando…
A multicenter-retrospective study of non-small-cell lung carcinoma harboring uncommon epidermal growth factor receptor (EGFR) mutations: different subtypes of EGFR exon 19 deletion-insertions exhibit the clinical characteristics and prognosis of non-small cell lung carcinoma
BACKGROUND: The aim of this study was to investigate the clinical features, immunohistochemistry (IHC), compound mutation, and prognosis of patients with non-small cell lung cancer (NSCLC) harboring exon 19 deletion-insertion mutations. METHODS: This retrospective analysis included 4,666 NSCLC patie...
Autores principales: | Chen, Ying, Xu, Jinhe, Zhang, Lei, Song, Yingfang, Wen, Wen, Lu, Jun, Zhao, Zhongquan, Kong, Wencui, Liu, Wei, Guo, Aiping, Santarpia, Mariacarmela, Yamada, Tadaaki, Cai, Xiuyu, Yu, Zongyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902088/ https://www.ncbi.nlm.nih.gov/pubmed/35280318 http://dx.doi.org/10.21037/tlcr-22-48 |
Ejemplares similares
-
Outcomes in Patients With Lung Adenocarcinoma With Transformation to Small Cell Lung Cancer After EGFR Tyrosine Kinase Inhibitors Resistance: A Systematic Review and Pooled Analysis
por: Xu, Jinhe, et al.
Publicado: (2022) -
Clinical characteristics of non-small cell lung cancer harboring mutations in exon 20 of EGFR or HER2
por: Takeda, Masayuki, et al.
Publicado: (2018) -
Clinical efficacy of first-generation EGFR-TKIs in patients with advanced non-small-cell lung cancer harboring EGFR exon 20 mutations
por: Chen, Dan, et al.
Publicado: (2016) -
Emerging therapies for non-small cell lung cancer harboring EGFR exon 20 insertion mutations: narrative review
por: Watanabe, Naohiro, et al.
Publicado: (2022) -
Sequential treatment in advanced non–small cell lung cancer harboring EGFR mutations
por: Hsu, Ping-Chih, et al.
Publicado: (2022)